» Articles » PMID: 15557587

Initial Viral Load and the Outcomes of SARS

Abstract

Background: Severe acute respiratory syndrome (SARS) is caused by a novel coronavirus. It may progress to respiratory failure, and a significant proportion of patients die. Preliminary data suggest that a high viral load of the SARS coronavirus is associated with adverse outcomes in the intensive care unit, but the relation of viral load to survival is unclear.

Methods: We prospectively studied an inception cohort of 133 patients with virologically confirmed SARS who were admitted to 2 general acute care hospitals in Hong Kong from Mar. 24 to May 4, 2003. The patients were followed until death or for a minimum of 90 days. We used Cox proportional hazard modelling to analyze potential predictors of survival recorded at the time of presentation, including viral load from nasopharyngeal specimens (measured by quantitative reverse transcriptase polymerase chain reaction [PCR] of the SARS-associated coronavirus).

Results: Thirty-two patients (24.1%) met the criteria for acute respiratory distress syndrome, and 24 patients (18.0%) died. The following baseline factors were independently associated with worse survival: older age (61-80 years) (adjusted hazard ratio [HR] 5.24, 95% confidence interval [CI] 2.03-13.53), presence of an active comorbid condition (adjusted HR 3.36, 95% CI 1.44-7.82) and higher initial viral load of SARS coronavirus, according to quantitative PCR of nasopharyngeal specimens (adjusted HR 1.21 per log10 increase in number of RNA copies per millilitre, 95% CI 1.06-1.39).

Interpretation: We found preliminary evidence that higher initial viral load is independently associated with worse prognosis in SARS. Mortality data for patients with SARS should be interpreted in light of age, comorbidity and viral load. These considerations will be important in future studies of SARS.

Citing Articles

SARS-CoV-2 specific adaptations in N protein inhibit NF-κB activation and alter pathogenesis.

Guo X, Yang S, Cai Z, Zhu S, Wang H, Liu Q J Cell Biol. 2024; 224(1).

PMID: 39680116 PMC: 11648720. DOI: 10.1083/jcb.202404131.


Immune Cells Are Differentially Affected by SARS-CoV-2 Viral Loads in K18-hACE2 Mice.

Kim J, Kim S, Kim J, Noh H, Lee S, Jeong H Immune Netw. 2024; 24(2):e7.

PMID: 38725670 PMC: 11076298. DOI: 10.4110/in.2024.24.e7.


Propylene glycol inactivates respiratory viruses and prevents airborne transmission.

Styles C, Zhou J, Flight K, Brown J, Lewis C, Wang X EMBO Mol Med. 2023; 15(12):e17932.

PMID: 37970627 PMC: 10701621. DOI: 10.15252/emmm.202317932.


Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severity.

Petrone V, Fanelli M, Giudice M, Toschi N, Conti A, Maracchioni C Front Microbiol. 2023; 14:1155624.

PMID: 37283924 PMC: 10239953. DOI: 10.3389/fmicb.2023.1155624.


Correlation of viral loads in disease transmission could affect early estimates of the reproduction number.

Harris T, Geard N, Zachreson C J R Soc Interface. 2023; 20(202):20220827.

PMID: 37132229 PMC: 10154938. DOI: 10.1098/rsif.2022.0827.


References
1.
Poon L, Wong O, Chan K, Luk W, Yuen K, Peiris J . Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS). Clin Chem. 2003; 49(6 Pt 1):953-5. PMC: 7108127. DOI: 10.1373/49.6.953. View

2.
Fouchier R, Kuiken T, Schutten M, van Amerongen G, van Doornum G, van den Hoogen B . Aetiology: Koch's postulates fulfilled for SARS virus. Nature. 2003; 423(6937):240. PMC: 7095368. DOI: 10.1038/423240a. View

3.
Peiris J, Chu C, Cheng V, Chan K, Hung I, Poon L . Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003; 361(9371):1767-72. PMC: 7112410. DOI: 10.1016/s0140-6736(03)13412-5. View

4.
Nicholls J, Poon L, Lee K, Ng W, Lai S, Leung C . Lung pathology of fatal severe acute respiratory syndrome. Lancet. 2003; 361(9371):1773-8. PMC: 7112492. DOI: 10.1016/s0140-6736(03)13413-7. View

5.
Booth C, Matukas L, Tomlinson G, Rachlis A, Rose D, Dwosh H . Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003; 289(21):2801-9. DOI: 10.1001/jama.289.21.JOC30885. View